1 Pharmacological activation of IKr in models of long QT Type 2 risks overcorrection of repolarization.

2 ips cells for modelling and treatment of retinal diseases

3 Genotyping, generation and proteomic profiling of the first human autosomal dominant osteopetrosis type II-specific induced pluripotent stem cells.

4 Osteopetrotic induced pluripotent stem cells derived from patients with different disease-associated mutations by non-integrating reprogramming methods.

5 Applying hydrodynamic pressure to efficiently generate induced pluripotent stem cells via reprogramming of centenarian skin fibroblasts.

6 Generation of two spinal muscular atrophy (SMA) type I patient-derived induced pluripotent stem cell (iPSC) lines and two SMA type II patient-derived iPSC lines.

7 Generation of induced pluripotent stem cell line, ICGi007-A, by reprogramming peripheral blood mononuclear cells from a patient with Huntington's disease.

8 Reference Transcriptome for Deriving Marmoset Induced Pluripotent Stem Cells.

9 Optimization of episomal reprogramming for generation of human induced pluripotent stem cells from fibroblasts.

10 Generation of transgene-free porcine intermediate type induced pluripotent stem cells.

11 Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.

12 Generation of CSi001-A, a transgene-free, induced pluripotent stem cell line derived from a Parkinson Disease (PD) patient.

13 Oral Mucosa-Derived Induced Pluripotent Stem Cells from Patients with Ectrodactyly-Ectodermal Dysplasia-Clefting Syndrome.

14 Optimizing the method for generation of integration-free induced pluripotent stem cells from human peripheral blood.

15 Generation of urine-derived induced pluripotent stem cells from a patient with phenylketonuria.

16 Seamless Genetic Conversion of SMN2 to SMN1 via CRISPR/Cpf1 and Single-Stranded Oligodeoxynucleotides in Spinal Muscular Atrophy Patient-Specific Induced Pluripotent Stem Cells.

17 Comparative characterization of human induced pluripotent stem cells (hiPSC) derived from patients with schizophrenia and autism

18 Chimeric G-CSF Receptor-Mediated STAT3 Activation Contributes to Efficient induction of Cardiomyocytes from Mouse Induced Pluripotent Stem Cells.

19 Recent advances of induced pluripotent stem cells application in neurodegenerative diseases

20 Three-dimensional decellularized amnion membrane scaffold promotes the efficiency of male germ cells generation from human induced pluripotent stem cells.

21 Generation of three induced pluripotent stem cell lines from postmortem tissue derived following sudden death of a young patient with STXBP1 mutation.

22 Induced pluripotent stem cell-derived mesenchymal stem cells prolong hind limb survival in a rat vascularized composite allotransplantation model.

23 Correction to: Particulate matter 2.5 induced arrhythmogenesis mediated by TRPC3 in human induced pluripotent stem cell-derived cardiomyocytes.

24 Strategies for the expansion of human induced pluripotent stem cells as aggregates in single-use Vertical-Wheel™ bioreactors.

25 microRNA and mRNA interactions in induced pluripotent stem cell reprogramming of lymphoblastoid cell lines.

26 Effect of different feeding schedules on the survival and neural differentiation of human embryonic and induced pluripotent stem cells

27 Amelioration of intracellular Ca regulation by exon-45 skipping in Duchenne muscular dystrophy-induced pluripotent stem cell-derived cardiomyocytes.

28 Gene expression and cytosine DNA methylation alterations in induced pluripotent stem-cell-derived human hepatocytes treated with low doses of chemical carcinogens.

29 Pathogenesis of fulminant type 1 diabetes: Genes, viruses and the immune mechanism, and usefulness of patient-derived induced pluripotent stem cells for future research

30 Generation of an induced pluripotent stem cell line (SYSUi002-A) from a patient with coronary slow flow phenomenon.

31 Efficient Production of Hepatocyte-like Cells from Human-induced Pluripotent Stem Cells by Optimizing Growth Factors

32 Improved methods for the differentiation of hypothalamic vasopressin neurons using mouse induced pluripotent stem cells.

33 Micro-Engineered Models of Development Using Induced Pluripotent Stem Cells.

34 Increased Ca signaling in neurons derived from ASD induced pluripotent stem cells.

35 Cellular and molecular characterization of multiplex autism in human induced pluripotent stem cell-derived neurons.

36 A hybrid microfluidic system for regulation of neural differentiation in induced pluripotent stem cells.

37 Immune potential of allogeneic equine induced pluripotent stem cells.

38 Non-viral reprogramming and induced pluripotent stem cells for cardiovascular therapy.

39 Extracellular Vesicles Derived from Induced Pluripotent Stem Cells Promote Renoprotection in Acute Kidney Injury Model.

40 Generation of two LRRK2 homozygous knockout human induced pluripotent stem cell lines using CRISPR/Cas9.

41 Establishment of SIAISi002-A, an induced pluripotent stem cell (iPSC) line from 39-year old healthy female donor with a family history of Alzheimer's disease (AD) and two copies of APOE4 gene.

42 Cell body shape and directional movement stability in human-induced pluripotent stem cell-derived dopaminergic neurons

43 In vitro modelling of alveolar repair at the air-liquid interface using alveolar epithelial cells derived from human induced pluripotent stem cells

44 Therapeutic efficacy of catalpol against apoptosis in cardiomyocytes derived from human induced pluripotent stem cells

45 Author Correction: Role of astroglia in Down’s syndrome revealed by patient-derived human-induced pluripotent stem cells (Nature Communications, (2014), 5, 1, (4430), 10.1038/ncomms5430)

46 Generation of four induced pluripotent stem cell lines (FHUi003-A, FHUi003-B, FHUi004-A and FHUi004-B) from two affected individuals of a familial neurohypophyseal diabetes insipidus family.

47 melanin transfer in human 3d skin equivalents generated exclusively from induced pluripotent stem cells.

48 differentiation of induced pluripotent stem cells into male germ cells in vitro through embryoid body formation and retinoic acid or testosterone induction

49 generation and characterization of a human induced pluripotent stem (ips) cell line derived from an acute myeloid leukemia patient evolving from primary myelofibrosis carrying the calr 52 bp deletion and the asxl1 p.r693x mutation

50 kajian induced pluripotent stemcell (ips) (harapan dan tantangan)

51 proarrhythmia risk prediction using human induced pluripotent stem cell-derived cardiomyocytes

52 generation of a human induced pluripotent stem cell (ipsc) line from a patient with family history of diabetes carrying a c18r mutation in the pdx1 gene

53 generation of induced pluripotent stem cells (aro-ipsc1-11) from a patient with autosomal recessive osteopetrosis harboring the c.212 + 1g > t mutation in snx10 gene

54 transplantation of human induced pluripotent stem cell-derived cardiomyocytes improves myocardial function and reverses ventricular remodeling in infarcted rat hearts

55 generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line sca3.b11

56 recent progress in the regeneration of spinal cord injuries by induced pluripotent stem cells

57 utility of lymphoblastoid cell lines for induced pluripotent stem cell generation

58 generation of a clonal induced pluripotent stem cell (ipsc) line expressing the mutant mecp2 allele from a rett syndrome patient fibroblast line

59 efficient generation of myelinating oligodendrocytes from primary progressive multiple sclerosis patients by induced pluripotent stem cells

60 factor-reduced human induced pluripotent stem cells efficiently differentiate into neurons independent of the number of reprogramming factors

61 establishment of mui009 – a human induced pluripotent stem cells from a 32 year old male with homozygous β°-thalassemia coinherited with heterozygous α-thalassemia 2

62 generation of induced pluripotent stem cell (ipsc) line from charcot-marie-tooth disease patient with mpz mutation (cmt1b)

63 rock inhibitor primes human induced pluripotent stem cells to selectively differentiate towards mesendodermal lineage via epithelial-mesenchymal transition-like modulation

64 putative epimutagens in maternal peripheral and cord blood samples identified using human induced pluripotent stem cells

65 inflammatory responses and barrier function of endothelial cells derived from human induced pluripotent stem cells

66 targeted correction and restored function of the cftr gene in cystic fibrosis induced pluripotent stem cells

67 scalable generation of universal platelets from human induced pluripotent stem cells

68 generation of a pxr reporter human induced pluripotent stem cell line (pxr-mcherry hipsc) using the crispr/cas9 system

69 the promise and challenge of induced pluripotent stem cells for cardiovascular applications

70 research on induced pluripotent stem cells and the application in ocular tissues

71 a panel of cpg methylation sites distinguishes human embryonic stem cells and induced pluripotent stem cells

72 generation of a human induced pluripotent stem cell line from a 65-year old healthy female donor with chinese han genetic background

73 ca2+-currents in human induced pluripotent stem cell-derived cardiomyocytes - effects of two different culture conditions

74 generation of an induced pluripotent stem cell line from a 39-year-old female patient with severe-to-profound non-syndromic sensorineural hearing loss and a a1555g mutation in the mitochondrial mtrnr1 gene

75 cgmp-manufactured human induced pluripotent stem cells are available for pre-clinical and clinical applications

76 establishment of an induced pluripotent stem cell (ipsc) line from a 9-year old male with autism spectrum disorder (asd)

77 induced pluripotent stem cell as a new source for cancer immunotherapy

78 derivation of a disease-specific human induced pluripotent stem cell line from a biliary atresia patient

79 mesenchymal and induced pluripotent stem cells: general insights and clinical perspectives

80 comparison of 2d and 3d neural induction methods for the generation of neural progenitor cells from human induced pluripotent stem cells

81 reprogramming human endometrial fibroblast into induced pluripotent stem cells

82 ctip-specific roles during cell reprogramming have long-term consequences in the survival and fitness of induced pluripotent stem cells

83 an integration-free, virus-free rhesus macaque induced pluripotent stem cell line (ripsc90) from embryonic fibroblasts

84 generation of a sox2 reporter human induced pluripotent stem cell line using crispr/sacas9

85 vaccination with human induced pluripotent stem cells creates an antigen-specific immune response against hiv-1 gp160

86 generation of induced pluripotent stem cells from a patient with parkinson's disease carrying lrrk2 p.i2012t mutation

87 generation of induced pluripotent stem cells (ipscs) from a hereditary spastic paraplegia patient carrying a homozygous y275x mutation in cyp7b1 (spg5)

88 comparative study of human embryonic stem cells (hesc) and human induced pluripotent stem cells (hipsc) as a treatment for retinal dystrophies

89 prospects and challenges of induced pluripotent stem cells in equine health

90 ion channelopathies in human induced pluripotent stem cell derived cardiomyocytes: a dynamic clamp study with virtual ik1

91 Generation of an induced pluripotent stem cell line FDHPIi001-A derived from a female patient with WDR45-related neurodegeneration disease carrying non-canonical splice site c.344 + 5G > T.

Keyword Connections

Journals

Research Groups

Bibliographies